These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11015641)

  • 21. The BALANCE trial.
    Fountoulakis KN
    Lancet; 2010 Apr; 375(9723):1343-4; author reply 1344. PubMed ID: 20399972
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful reintroduction of valproic acid after the occurrence of pancytopenia.
    Stewart JT
    Am J Geriatr Pharmacother; 2011 Oct; 9(5):351-3. PubMed ID: 21962938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid reversal of corticosteroid-induced mania with sodium valproate: a case series of 20 patients.
    Roxanas MG; Hunt GE
    Psychosomatics; 2012; 53(6):575-81. PubMed ID: 23157995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The BALANCE trial.
    Basu D
    Lancet; 2010 Apr; 375(9723):1343; author reply 1344. PubMed ID: 20399973
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ergenyl chronospheres in bipolar disorders].
    Grunze H
    Krankenpfl J; 2005; 43(7-10):213. PubMed ID: 16515285
    [No Abstract]   [Full Text] [Related]  

  • 26. [Inappropriate antidiuretic hormone secretion induced by sodium valproate].
    Bève E; Beck E; Pinto E; Ansseau M
    Rev Med Liege; 2010 Jan; 65(1):6-9. PubMed ID: 20222501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case report that suggested that aspirin's effects on valproic acid metabolism may contribute to valproic acid's inducer effects on clozapine metabolism.
    Riesselman A; Strobl B; Cooley AT; de Leon J
    J Clin Psychopharmacol; 2013 Dec; 33(6):812-4. PubMed ID: 24113673
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of divalproex extended release in psychiatric patients.
    Jackson RS; Venkataraman S; Atkins RB; Owens M
    Ann Clin Psychiatry; 2006; 18(4):273-4. PubMed ID: 17162629
    [No Abstract]   [Full Text] [Related]  

  • 30. Comorbidity of keratosis follicularis (Darier's Disease) and bipolar affective disorder: an indication for valproate instead of lithium.
    Ehrt U; Brieger P
    Gen Hosp Psychiatry; 2000; 22(2):128-9. PubMed ID: 10896494
    [No Abstract]   [Full Text] [Related]  

  • 31. Intravenous valproate use in bipolar II disorder after gastric bypass surgery.
    Semion K; Dorsey J; Bourgeois J
    J Neuropsychiatry Clin Neurosci; 2005; 17(3):427-9. PubMed ID: 16179671
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of sodium valproate and haloperidol in the management of acute mania: a randomized open-label comparative study.
    Sekhar S; Kalra B; Mendhekar DN; Tekur U
    J Clin Pharmacol; 2010 Jun; 50(6):688-92. PubMed ID: 20075184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Affective Recurrences in Bipolar Disorder After Switching From Lithium to Valproate or Vice Versa: A Series of 57 Cases.
    Rosso G; Solia F; Albert U; Maina G
    J Clin Psychopharmacol; 2017 Apr; 37(2):278-281. PubMed ID: 28129310
    [No Abstract]   [Full Text] [Related]  

  • 34. Brain oscillatory responses in patients with bipolar disorder manic episode before and after valproate treatment.
    Ozerdem A; Güntekin B; Tunca Z; Başar E
    Brain Res; 2008 Oct; 1235():98-108. PubMed ID: 18644356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of valproate plasma concentrations and dose in bipolar affective disorder.
    Perry PJ; Bever-Stille KA; Arndt S; Gundersen S
    J Clin Psychopharmacol; 2000 Apr; 20(2):277-9. PubMed ID: 10770477
    [No Abstract]   [Full Text] [Related]  

  • 36. Dosing of divalproex extended release.
    Feifel D
    J Clin Psychiatry; 2007 Jul; 68(7):1146-7; author reply 1147. PubMed ID: 17685756
    [No Abstract]   [Full Text] [Related]  

  • 37. Intravenous valproate in neuropsychiatry.
    Norton JW; Quarles E
    Pharmacotherapy; 2000 Jan; 20(1):88-92. PubMed ID: 10641979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerability of oral loading of divalproex sodium in the treatment of acute mania.
    Martinez JM; Russell JM; Hirschfeld RM
    Depress Anxiety; 1998; 7(2):83-6. PubMed ID: 9614597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mood stabilizers in Asperger's syndrome.
    Duggal HS
    Aust N Z J Psychiatry; 2001 Jun; 35(3):390-1. PubMed ID: 11437822
    [No Abstract]   [Full Text] [Related]  

  • 40. Combination treatment with aripiprazole and valproic acid for acute mania: an 8-week, single-blind, randomized controlled trial.
    Jeong HG; Lee MS; Ko YH; Han C; Jung IK
    Clin Neuropharmacol; 2012; 35(3):97-102. PubMed ID: 22592508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.